Jinxin Fertility Group (HKSE:01951) EBITDA Margin % : 15.31% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Jinxin Fertility Group EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Jinxin Fertility Group's EBITDA for the six months ended in Dec. 2023 was HK$244 Mil. Jinxin Fertility Group's Revenue for the six months ended in Dec. 2023 was HK$1,591 Mil. Therefore, Jinxin Fertility Group's EBITDA margin for the quarter that ended in Dec. 2023 was 15.31%.

Jinxin Fertility Group EBITDA Margin % Historical Data

The historical data trend for Jinxin Fertility Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinxin Fertility Group EBITDA Margin % Chart

Jinxin Fertility Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

Get a 7-Day Free Trial

40.63

34.56

35.25

20.56

29.71

Jinxin Fertility Group Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBITDA Margin %	Get a 7-Day Free Trial									26.89	23.43	-3.30	24.08	15.31

Competitive Comparison of Jinxin Fertility Group's EBITDA Margin %

For the Medical Care Facilities subindustry, Jinxin Fertility Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jinxin Fertility Group's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Jinxin Fertility Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Jinxin Fertility Group's EBITDA Margin % falls into.

Jinxin Fertility Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Jinxin Fertility Group's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	906.346	/	3050.451
	=	29.71 %

Jinxin Fertility Group's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	243.611	/	1591.453
	=	15.31 %

Jinxin Fertility Group (HKSE:01951) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Jinxin Fertility Group EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Jinxin Fertility Group's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jinxin Fertility Group (HKSE:01951) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jinxin Fertility Group Ltd (HKSE:01951) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

3NX:Germany

Address

No. 301, North Jingsha Road, Jinjiang District, Sichuan, Chengdu, CHN

Website

https://www.jxr-fertility.com

Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm generates its revenue from Assisted reproductive services, management services, and ancillary medical services. Geographically, it generates a majority of its revenue from the People's Republic of China.

Executives

Jinxin Fertility Investment Group Limited	2101 Beneficial owner
Hrc Investment Holding, Llc
Hhlr Advisors, Ltd.	2102 Investment manager
Hhlr Fund, L.p.	2101 Beneficial owner
Morgan Stanley	2201 Interest of corporation controlled by you
Blackrock, Inc.	2201 Interest of corporation controlled by you
Hillhouse Capital Advisors, Ltd.	2102 Investment manager
Gaoling Fund, L.p.	2101 Beneficial owner

Jinxin Fertility Group (HKSE:01951) Headlines

No Headlines